Oxford Society of Ageing and Longevity

Steve Horvath - Altos Lab
2023-11-15
Epigenetic Ageing Clocks in Mammals and Rejuvenation Strategies
Oxford Examination Schools East Wing
REGISTER NOW! – Organised by The Longevity Forum

Investment Review in Longevity
2023-11-27 - 2023-12-03
Investment Opportunities in the Longevity Sector
Saïd Business School

The $101 Million XPRIZE Healthspan: Insights from Prof. Jamie Justice
2024-03-06 18:00 - 20:00 UTC
Join us for an exclusive deep dive into the $101 Million XPRIZE Healthspan with Prof. Jamie Justice.
Location:
Fitzhugh Auditorium
Walton Street Oxford OX1 2HG
https://www.eventbrite.co.uk/e/the-101-million-xprize-healthspan-insights-from-prof-jamie-justice-tickets-854004529537?aff=oddtdtcreator

Investing In Longevity
2024-04-11 12:00 - 13:00 | Virtual
Overview: Join us for an enlightening online conversation with two visionary investors at the forefront of the longevity sector, Christian Angermayer and Lorenzo Thione. Dive into the world where technology intersects with the quest for a longer, healthier life. This event is a unique opportunity to explore the cutting-edge of investing in longevity, mental health, and the technologies set to revolutionize our future.
The Event:The Oxford Society of Ageing and Longevity is proud to present an exclusive online dialogue between Christian Angermayer, a leading figure in the psychedelic and longevity investment landscape, and Lorenzo Thione, a serial entrepreneur whose ventures span technology, art, and social value.
Christian Angermayer, with his profound portfolio including the world’s largest investment in psychedelics, aims to address the global mental health crisis through companies like atai Life Sciences. His ventures into longevity with Rejuveron Life Sciences and Cambrian Biopharma promise to extend human lifespan with quality health. As a founder and lead investor in multiple unicorns and decacorns, Christian’s expertise spans from FinTech & Crypto to Future Tech, showcasing a commitment to shaping a future where technology enhances life at every stage.
Lorenzo Thione stands at the intersection of innovation and social impact, with a history of founding and investing in companies that redefine industries. From Powerset’s integration into Microsoft Bing to producing Tony-award-winning Broadway shows, Lorenzo’s diverse portfolio highlights his unique blend of creativity and entrepreneurial acumen. An active supporter of the LGBT entrepreneurial community and a passionate investor in health, longevity, and performance optimization, Lorenzo’s investments reflect his commitment to societal betterment and individual well-being.
This conversation will bridge their collective insights on investing in technologies that promise not only to extend life but to enrich its quality. Attendees will gain unparalleled access to discussions on the future of health, the potential of psychedelics in mental health treatment, and the role of technology in shaping the longevity sector.
Please register to secure your virtual spot and mark your calendar for this exciting online event.
Christian Angermayer Biography:
Christian Angermayer is a visionary entrepreneur and investor, deeply involved in the advancement of the Next Human Agenda, focusing on technologies that enhance human life span and quality. As the founder of Apeiron Investment Group, with over USD 2.5 billion under management, Christian’s influence spans across Life Sciences, FinTech & Crypto, Future Tech, and beyond. His significant contributions to the field of psychedelics through atai Life Sciences, aim at revolutionizing mental health treatment. Furthermore, Christian’s passion for longevity is evident in his founding of biotech companies like Rejuveron Life Sciences and Cambrian Biopharma, which are at the forefront of developing therapies to extend human life and health spans. His broad portfolio reflects a commitment to leveraging technology for enhancing human health and happiness, making him a leading figure in the investment in life-extending innovations.
Lorenzo Thione Biography:
Lorenzo Thione is a distinguished serial entrepreneur and investor, known for his strategic intersections of technology, art, commerce, and social value. Beyond his success in co-founding companies like Powerset and his notable achievements in Broadway production, Lorenzo has carved a niche for himself in the longevity and health optimization space. His personal passion for enhancing human health and performance has translated into a series of targeted investments in cutting-edge health technologies. Among his notable contributions to the field are investments in Whoop, Levels, Vessel, Better Brand, Oura, Recess, Ergatta, Minicircle, Loyal, and Renewal, including some of Christian’s companies – Rejuveron, Cambrian Biopharma and Atai Life Sciences. through his involvement with Gaingels. These companies represent the forefront of health and wellness technology, focusing on everything from wearable fitness and health tracking devices to nutrition and longevity research. His role as an active investor and advisor in these ventures underscores his belief in the power of technology to enhance human well-being, positioning him as a key figure in the push towards a future where longevity and health optimization are within reach for all.

Longevity Startup Panel: Will you live forever?
2024-11-14 18:00 - 20:00 | T.S. Eliot Theatre, Merton College, Merton Street, OX1 4JD, T.S. Eliot Theatre, Merton College, Merton Street, Oxford, OX1 4JD
Are you fascinated by longevity and interested in extending your life span? Curious about the latest breakthroughs in this field? Join us for our Longevity Startup Panel, featuring some of the leading startups advancing these innovations.
Our distinguished panelists include:
💡 Shakiba Kaveh, Co-Founder and CEO of Mitra Bio — a London-based company pioneering non-invasive diagnostics for skin aging.
💡 Peter Hamley, former CSO at Samsara Therapeutics, now preparing to launch a new Oxford-based venture focused on partial cellular reprogramming.
💡 Brendan Swain, CSO & Co-Founder of Shift Bioscience, a Cambridge company specializing in cellular reprogramming.
We look forward to a compelling discussion on current trends and the future of longevity science. This is an event jointly organised ​by Oxford Entrepreneurs, the Oxford Society for Ageing and Longevity and the Biohacking Society.

The Enhanced Games: A talk with Dr Aron D Souza
2025-01-24 18:00 | Cohen Quad. The Fitzhugh Auditorium
Join us for a captivating evening this Friday at Cohen Quad, Exeter College with special guest speaker Dr. Aron D’Souza, an entrepreneur, innovator, and the visionary behind the Enhanced Games
Aron D’Souza’s work spans multiple fields, from business and academia to sports and technology. He has advised organizations, contributed to policy development, and fostered significant global collaborations. Now, Aron is taking center stage as the driving force behind the Enhanced Games, an upcoming international sporting event reimagining performance and pushing the boundaries of what athletes can achieve. This visionary project has received support from influential investors, including Peter Thiel.
Engage with Aron directly during an open Q&A session, where you can explore the future of sport, ethics, and creativity in competition.
Whether you’re passionate about entrepreneurship, sports science, longevity or simply wish to be inspired by Dr. D’Souza, this talk promises to spark lively discussions and fresh perspectives.

The Gene Therapy Revolution
2025-03-13 18:00 - 20:00 | Cohen Quad. The Fitzhugh Auditorium
We are thrilled to invite you to an exclusive talk hosted by the Oxford Society of Ageing and Longevity (OSAL) featuring Dr. Patrick E. Sewell, MD, Co-Founder and Chief Scientist at TriplHelix Gene Therapies.
📅 Date: Thursday, 13th March
🕕 Time: 6:00 PM
📍 Location: Fitzhugh Auditorium, Cohen Quad, Walton St, Oxford OX1 2HG
Dr. Sewell is a pioneering figure in gene therapy, regenerative medicine, and interventional oncology. With over three decades of groundbreaking work, including systemic gene therapy for longevity, stem cell innovations, and minimally invasive cancer treatments, he is at the forefront of reshaping modern medicine.
Join us as Dr. Sewell explores how gene therapy is ushering in a new era of longevity and what this means for the future of health and human enhancement. This is a unique opportunity to engage with a world-leading scientist and discuss the latest advancements in the field.

Longevity Biotech Social
2025-08-01 19:00 - 22:00 | Oxford Blue, 32 Marston St, Oxford, United Kingdom, OX4 1JU
Join us for an informal evening bringing together scientists, entrepreneurs, investors, students, and anyone curious about the future of healthy aging and biotechnology.
​This is a casual networking event — no formal presentations, just real conversations, idea-sharing, and meeting like-minded people who care about longevity science and innovation.
​✅ Drinks: Drinks (including non-alcoholic options) are available for purchase at the venue — please note drinks are not included in the ticket. Everyone orders and pays individually at the bar.
✅ Age policy: Open to attendees aged 18+; please bring valid ID if you wish to buy alcohol.
✅ Accessibility: The venue is wheelchair accessible.
✅ All are welcome: Whether you work in biotech, are studying, investing, or simply curious about the science of living longer — you belong here.
✅ Community vibe: Come ready to chat, ask questions, and share your passion. Even if attendance is small, we’ll keep it friendly and meaningful.
​Come network, collaborate, and be part of the movement to shape the future of longevity.

VC Insights on the Future of Longevity Biotech
2025-08-22 20:00 - 21:30
Join us for an exclusive session with Sebastian Brunemeier, one of the most influential figures at the intersection of biotechnology, ageing research, and venture capital.
​Sebastian A. Brunemeier is a biotech VC and company builder focused on longevity & regenerative medicine. He is Co-Founder and General Partner of Healthspan Capital, and Partner at Long Game Ventures. Previously, he was Principal at Apollo Health Ventures, the largest longevity fund in the world, CIO and Co-Founder at Cambrian Biopharma, and Founder of Samsara Therapeutics. He was a DPhil (PhD) Clarendon Scholar in Biochemistry at the University of Oxford, a Fulbright Fellow, a Skaggs-Oxford Scholar at the Scripps Research Institute, and holds a dual MSc in Molecular Neuroscience and Biotech Business Management from University of Amsterdam.
​In this session, Sebastian will share insights on:

​The global longevity biotech investment landscape
​What makes a longevity startup investor-ready
​The intersection of science, entrepreneurship, and capital
​Career pathways for students and researchers in the field
​His own journey from academic ageing research to founding and funding frontier biotech ventures

​Open to all students, faculty, researchers, and future founders interested in biotech, aging science, and healthspan innovation.
​Event Highlights:

​Deep dive into the world of longevity investing and emerging biotech
​Learn what makes a longevity startup investor-ready
​Breathtaking view of London from the 32nd floor venue
​Complimentary Longevity Protein Shake Samples to fuel your healthspan journey

Rehydration OSAL's Welcome Social
2026-02-04 19:00 | Jesus College Bar, Turl Street, Oxford, OX1 3DW
Join us for our first social of the year to get to know members of the society and what other events we have in store this term!

Genflow Biosciences: Translating longevity research to the bedside
2026-02-16 18:00 | David Smith Lecture Theatre Department of Pharmacology Mansfield Road Oxford OX1 3QT United Kingdom, David Smith Lecture Theatre Department of Pharmacology Mansfield Road, Oxford United Kingdom, OX1 3QT, United Kingdom
Dr. Eric Leire is the Founder and CEO of Genflow Biosciences, a longevity gene therapy company listed on the London Stock Exchange. An MD and MBA (HEC/Kellogg), he combines research experience from the Harvard AIDS Institute with executive leadership at Pfizer and Biofund Venture Capital. Dr. Leire has guided multiple biotech companies to public listings (Nasdaq) and holds several pharmaceutical patents.

Early detection for dementia, an oxymoron? Examining the evidence from population studies
2026-03-10 18:00 | David Smith Lecture Theatre, Department of Pharmacology, Mansfield Road, Oxford OX1 3QT, David Smith Lecture Theatre, Department of Pharmacology, Mansfield Road,, Oxford, OX1 3QT
We’re delighted to invite you to an in‑person OSAL event with Professor Carol Brayne, one of the leading public health voices in dementia and ageing.
Early detection for dementia is often treated as an obvious good: find it earlier, fix it earlier. In this talk, Professor Brayne will challenge that simple narrative, drawing on decades of population‑based research to ask when dementia really becomes detectable, what “early” labels actually tell us about the future, and how screening can both help and harm.
She will explore:

How dementia trends have changed over time in real‑world populations
Why mild memory problems and “preclinical” labels do not always progress to dementia
The gap between tests/biomarkers and people’s lived cognitive function
The ethical and practical dilemmas of telling people they are “at risk” years before symptoms may—or may not—develop
